software, or any other electronic systems used to accurately report various direct or indirect payments made to HCPs as required by the new legislation. With the Sunshine Act now requiring the collection of data beginning August 1, 2013, the timing of this partnership benefits clinical trial sponsors looking to gain compliance and provide a comprehensive, automated solution for tracking total investigator spend, both direct and indirect, while alleviating a time-intensive burden from sponsors.
John Lewis, CEO of Aggregate Spend Solutions, stated, “We understand the complexities unique to transfer of value spend capture – working with multiple vendors, meeting-related expenses, and other issues. Our partnership with Clinverse allows us to provide our clients with our expertise and proven technology, while also providing them access to a centralized and scalable aggregate spend solution anchored by Clinverse’s proven investigator payment platform. We look forward to working with Clinverse and continuing to provide our clients with all of the services and technology required to meet the Sunshine Act reporting requirements that are looming.”
About Aggregate Spend Solutions, LLC
Aggregate Spend Solutions, LLC was formed as a result of the new and stringent reporting requirements of the Physicians Payment Sunshine Act. SpendMD™, sunshine tracking and reporting is the organization’s key software product that provides the Health and Life Science Industries with the only complete solution for tracking and reporting “indirect spend” for HCP Meetings. Based in Raleigh, North Carolina with global development centers, Aggregate Spend Solutions is a key leader in the design, development, implementation and support of data aggregation products and services. For more information, please visit http://www.spendmd.com.
About Clinverse, Inc.
Clinverse, Inc. is a global t
Page: 1 2 3 Related biology technology :1
Copyright©2012 Vocus, Inc.
All rights reserved
. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting2
. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations3
. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference4
. ACORN Research, LLC Announces Partnership with AdeptBio, LLC5
. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results6
. WuXi PharmaTech Announces Third-Quarter 2011 Results7
. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting8
. Spherix Announces Third Quarter Financial Results9
. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition10
. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition11
. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint